Advertisement
Screener

AMERICAN SHARED HOSPITAL SERVICES (AMS) Number of Reportable Segments

2.8 / 5 stars · 68/120 Roast Me

AMERICAN SHARED HOSPITAL SERVICES Number of Reportable Segments

AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Number of Reportable Segments of 200.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Notes

us-gaap:NumberOfReportableSegments · last filed 2026-08-13

  • AMERICAN SHARED HOSPITAL SERVICES number of reportable segments for the quarter ending 2026-03-31 was 200.00%, a 0.00% change year-over-year.
  • AMERICAN SHARED HOSPITAL SERVICES number of reportable segments for the quarter ending 2025-03-31 was 200.00%, a 0.00% change year-over-year.
  • AMERICAN SHARED HOSPITAL SERVICES number of reportable segments for the quarter ending 2024-03-31 was 200.00%, a 0.00% change year-over-year.
  • AMERICAN SHARED HOSPITAL SERVICES number of reportable segments for the quarter ending 2023-03-31 was 200.00%, a 0.00% change year-over-year.
  • AMERICAN SHARED HOSPITAL SERVICES number of reportable segments for fiscal 2025 was 200.00%, a 0.00% change from fiscal 2024.
  • AMERICAN SHARED HOSPITAL SERVICES number of reportable segments for fiscal 2024 was 200.00%, a 0.00% change from fiscal 2023.
  • AMERICAN SHARED HOSPITAL SERVICES number of reportable segments for fiscal 2023 was 200.00%, a 0.00% change from fiscal 2022.
  • AMERICAN SHARED HOSPITAL SERVICES number of reportable segments for fiscal 2022 was 200.00%, a 0.00% change from fiscal 2021.

pure

Period endNumber of Reportable Segments 3 monthNumber of Reportable Segments 6 monthNumber of Reportable Segments 9 monthNumber of Reportable Segments 12 monthNumber of Reportable Segments 15 month
2026-06-30200.00%
10-Q · filed 2026-08-13
2026-03-31200.00%
10-Q · filed 2026-05-14
2025-12-31200.00%
10-K · filed 2026-03-31
2025-09-30200.00%
10-Q/A · filed 2026-01-16
2025-06-30200.00%
10-Q · filed 2025-08-13
2025-03-31200.00%
10-Q · filed 2025-05-15
2024-12-31200.00%
10-K · filed 2026-03-31
2024-09-30200.00%
10-Q · filed 2024-11-14
2024-06-30200.00%
10-Q · filed 2024-08-14
2024-03-31200.00%
10-Q · filed 2024-05-15
2023-12-31200.00%
10-K · filed 2025-04-04
2023-09-30200.00%
10-Q · filed 2023-11-14
2023-06-30200.00%
10-Q · filed 2023-08-14
2023-03-31200.00%
10-Q · filed 2023-05-12
2022-12-31200.00%
10-K · filed 2024-04-01
2022-09-30200.00%
10-Q · filed 2022-11-10
2022-06-30200.00%
10-Q · filed 2022-08-15
2022-03-31200.00%
10-Q · filed 2022-05-12
2021-12-31200.00%
10-K · filed 2023-03-31
2021-09-30200.00%
10-Q · filed 2021-11-10
2021-06-30200.00%
10-Q · filed 2021-08-12
2020-12-31200.00%
10-K · filed 2022-03-30
2020-06-30100.00%
10-Q · filed 2021-11-10

segment

Period endNumber of Reportable Segments 3 monthNumber of Reportable Segments 6 monthNumber of Reportable Segments 9 monthNumber of Reportable Segments 12 month
2021-03-312.00 segment
10-Q · filed 2021-05-13
2020-12-312.00 segment
10-K · filed 2021-04-06
2019-09-301.00 segment
10-Q · filed 2019-11-07
2019-06-301.00 segment
10-Q · filed 2019-08-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45